Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Princeton BioMeditech is a private U.S. diagnostics company focused on rapid, point-of-care and in-home testing products. The company develops and manufactures immunoassay-based tests across cardiac care, infectious disease, fertility, drugs of abuse, tumor markers, veterinary, and food/environmental applications. Its portfolio includes branded product lines such as Status, Status First, BioSign, LifeSign, BioStrip, and OvuSign, with more than 70 rapid tests marketed globally. Princeton BioMeditech also offers OEM services and manufactures products under regulated quality systems, including cGMP and ISO 13485-certified operations. The business is best characterized as a commercial-stage in vitro diagnostics and medical device company rather than a therapeutic biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Princeton BioMedtech.